# PI Industries share price today (P I Industries Ltd, NSE: PIIND)

> PI Industries share price today: ₹2,185.00 at the NSE close on 3 November 2026, down 38.9% in a year. P I Industries (NSE: PIIND) is worth ₹33,151 crore, trades at a P/E of 30.7 and has closed between ₹2,051.00 and ₹3,758.30 over the past 52 weeks. > P I Industries Ltd's P/E is near the low end of its own history, higher than only 14% of past readings, and its quarterly results are still getting worse. PIIND · Pesticides/Agrochemicals · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/p-i-industries-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: ₹2,185.00 (−38.9% in a year)
- P/E: 30.7× (lower than 86% of the last 11 years)
- Revenue (Jun 2026): ₹1,702 Cr (−10.4% on a year ago)
- Profit (Jun 2026): ₹244 Cr (−39.0% on a year ago)
- Operating margin: 22.0% (−5.0 points on a year ago)
- ROCE: 15%, FY26
- ROIC: 10.8%, against a 12.0% cost of capital: −1.2 points

The main question: the P/E is near the low end of its own history, higher than only 14% of past readings, but results are getting worse. A low multiple can stay low until the quarters turn. ## What is the PI Industries share price today? P I Industries Ltd's share price was ₹2,185.00 at the close on 3 November 2026. It has been falling for 57 weeks. That is 19.7% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹2,051 and ₹3,758, and at that close it sat 8% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 30 weeks running. Over the last 11 years the share price moved +282% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 15 May 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at PI Industries this quarter? Three changes stood out: foreign funds (FIIs) cut their stake for 8 quarters in a row, profit down on a year earlier for 7 quarters in a row and revenue down on a year earlier for 5 quarters in a row. 1. Foreign funds (FIIs) cut their stake for 8 quarters in a row From 19% to 14.8% of the company by the September 2026 quarter. 2. Profit down on a year earlier for 7 quarters in a row In the June 2026 quarter profit was ₹244 crore, -39% on a year earlier. Why: Profit fell because the company is spending on research and on new businesses like biologicals and pharma before they earn money. Next results: check whether margin moves toward the full-year range and whether management separates raw material, pricing, mix and investment effects. From the earnings call on 12 Aug 2026. 3. Revenue down on a year earlier for 5 quarters in a row In the June 2026 quarter revenue was ₹1,702 crore, -10.4% on a year earlier. Why: Revenue fell because the export chemical business stayed weak as crop prices and demand were low. Next results: check whether export chemical volumes, pricing and order-book conversion show the promised second-half recovery. From the earnings call on 12 Aug 2026. ## What are PI Industries' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), PI Industries reported revenue of ₹1,702 crore, down 10.4% from ₹1,900 crore a year earlier, and a profit of ₹244 crore, down 39.0% from ₹400 crore. ### PI Industries results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹1,702 crore | ₹1,900 crore | −10.4% |
| Profit | ₹244 crore | ₹400 crore | −39.0% |
| Earnings per share | ₹16.10 | ₹26.36 | −38.9% |
| Operating margin | 22.0% | 27.0% | −5.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). PI Industries' management discussed these results on a call held on 12 August 2026; what it said is further down this page. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the PI Industries share price history? PI Industries closed at ₹2,185.00 on 3 November 2026, down 38.9% from ₹3,577.40 a year earlier (31 October 2025) and down 21.1% over five years. Its highest weekly close since March 2016 was ₹4,716.00 on 20 September 2024. ### PI Industries share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹2,051.00 | +6.5% |
| 1 month ago · 1 Oct 2026 | ₹2,236.00 | −2.3% |
| 6 months ago · 30 Apr 2026 | ₹3,054.80 | −28.5% |
| 1 year ago · 31 Oct 2025 | ₹3,577.40 | −38.9% |
| 3 years ago · 3 Nov 2023 | ₹3,489.20 | −37.4% |
| 5 years ago · 4 Nov 2021 | ₹2,767.70 | −21.1% |
| 10 years ago · 4 Nov 2016 | ₹836.60 | +161.2% |
| Earliest weekly close in our records · 11 Mar 2016 | ₹572.45 | +281.7% |
| Highest weekly close since March 2016 · 20 Sep 2024 | ₹4,716.00 | −53.7% |
| Lowest weekly close since March 2016 · 18 Mar 2016 | ₹562.90 | +288.2% |
| 52-week high (weekly close) · 7 Nov 2025 | ₹3,758.30 | −41.9% |
| 52-week low (weekly close) · 23 Oct 2026 | ₹2,051.00 | +6.5% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (560 weekly closes from 11 March 2016 to 3 November 2026.)

## What is the latest news on PI Industries? 3 Nov 2026: PI Industries closed at ₹2,185.00, up 6.5% on the week and down 2.3% on the month. 12 Aug 2026: PI Industries held its results call for April to June 2026. Management guided: FY27 revenue growth in the low double digits, with the positive trajectory maintained. ### Earlier

- 7 Aug 2026: ex-date for a dividend of ₹10 a share. - Results for April to June 2026: Revenue down 10.4% and profit down 39.0% on a year earlier. - 23 Feb 2026: ex-date for an interim dividend of ₹5 a share. ## What dividend does PI Industries pay? PI Industries paid ₹15 a share in regular dividends in the 12 months to 4 November 2026 (2 payments), a yield of 0.69% at the ₹2,185.00 close on 3 November 2026. The last was a dividend of ₹10 a share, ex-date 7 August 2026. ### PI Industries dividends since 1 April 2021

| Ex-date | Dividend per share | Type | Record date |
| --- | --- | --- | --- |
| 7 Aug 2026 | ₹10 | Dividend | same day |
| 23 Feb 2026 | ₹5 | Interim | same day |
| 7 Aug 2025 | ₹10 | Dividend | same day |
| 14 Feb 2025 | ₹6 | Interim | same day |
| 20 Aug 2024 | ₹9 | Dividend | same day |
| 21 Feb 2024 | ₹6 | Interim | same day |
| 11 Aug 2023 | ₹5.50 | Dividend | n/a |
| 24 Feb 2023 | ₹4.50 | Interim | same day |
| 25 Aug 2022 | ₹3 | Dividend | n/a |
| 14 Feb 2022 | ₹3 | Interim | 15 Feb 2022 |
| 6 Sep 2021 | ₹2 | Dividend | n/a |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 5 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. P I Industries Ltd paid out 17% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years. (From the NSE corporate-actions record, read 4 November 2026.)

## What did PI Industries management say on the latest results call? On the call for April to June 2026, held on 12 August 2026, PI Industries' management guided: FY27 revenue growth in the low double digits, with the positive trajectory maintained. > “We expect EBITDA for FY27 to be in the range of 25-26%.”
> Sanjay Agarwal, on the call for April to June 2026

### What management guided

- FY27 operating margin in the 25-26% range. - FY27 new product launches: 4-5 molecules mainly in X-Chem, plus a couple of electronic chemicals and 1-2 pharma products. - Pioxaniliprole launch in India within FY27; one overseas filing next year and another the following year. - FY27 standard capital spending ₹700-800 crore. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijorifinance.com/insight/india/2507/Conference Call/CC-Aug26.pdf). (From the call for April to June 2026, 12 August 2026.)

## What to watch in PI Industries' next results? When PI Industries reports July to September 2026, these are the 3 checks that show whether the story is still on course. First: Export CSM volumes, pricing and order-book conversion to demonstrate the promised second-half recovery rather than continued cycle pressure. - What to check (from the call)
- Export CSM volumes, pricing and order-book conversion to demonstrate the promised second-half recovery rather than continued cycle pressure. - Pioxaniliprole regulatory progress and Indian commercial launch before the relevant domestic crop season. - Global biologicals trials converting into sales, and pharma customer orders reducing CRDMO timing volatility. ## Which stock lists is PI Industries on? PI Industries is on 2 of our India lists: 52 week high & low and Small & mid cap stocks. - [52 week high & low 52-week position: Near 52-week low](https://www.sectoralpha.in/52-week-high-stocks-india)
- [Small & mid cap stocks Size rank in India: 264](https://www.sectoralpha.in/small-cap-stocks-india)

## Is PI Industries profitable? P I Industries Ltd earned ₹244 Cr of net profit in the Jun 2026 quarter, −39.0% on the same quarter a year earlier. Full-year FY26 profit was ₹1,321 Cr. Over 10 years profit has grown 15.5% a year on average. That is 14.3% of the quarter's revenue. The same quarter a year earlier earned ₹400 Cr. For the full year, FY26 profit was ₹1,321 Cr (−20.4% on the year before). Why profit moved: revenue changed −10.4% on a year earlier and the margin moved −5.0 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed −28.6% and revenue −16.5%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does PI Industries make, and is it growing? P I Industries Ltd reported ₹1,702 Cr of revenue in the Jun 2026 quarter, −10.4% on the same quarter a year earlier. Over 10 years it has grown 12.3% a year on average. The last full year, FY26, came in at ₹6,714 Cr. The last four reported quarters add to ₹6,515 Cr. FY26 revenue was ₹6,714 Cr, −15.8% on the year before. Recent pace: the last four quarters grew −16.5% on average, against 12.3% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −16.6%, against −8.8% a year over the last 8 quarters (rolling over); profit over the last 12 months grew −27.7%, against −18.4% a year (rolling over). ## How much of every ₹100 of sales does PI Industries keep? P I Industries Ltd's operating margin was 22.0% in the Jun 2026 quarter, 5.0 percentage points lower than the same quarter a year ago. Across 13 years it has been between 19.0% and 28.0%. The latest quarter is within that range. Why the margin moved: operating margin changed −5.7 percentage points on the year while gross margin changed −0.7 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is PI Industries' profit turning into cash? Over the last 3 years, 84% of P I Industries Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹474 Cr of operating cash against ₹1,321 Cr of profit. After ₹1,298 Cr of spending on assets, free cash was −₹824 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 84% of profit came in as cash: the cash cycle got 26 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. What to look at next: the bigger use of cash is spending on new assets, at 3.7× depreciation over three years. The next section checks what that spending is building. ## Where does PI Industries' cash go? P I Industries Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 119 days in FY26, up from 93 days in FY21. It spent ₹3,979 Cr on assets over the last 3 years. Customers take 88 days to pay, and stock sits for 157 days on average. At FY26 sales of ₹6,714 Cr, each day of that cycle ties up about ₹18.4 Cr, so roughly ₹2,189 Cr is tied up in the business at any time. FY26: customers took 88 days to pay and stock sat for 157 days, about 5.2 months of sales sitting as stock, for a full cycle of 119 days, longer than FY21's 93. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 157 days. Customers pay about 88 days after that. Suppliers are paid at 125 days. Together that makes the 119-day cycle. Spending on assets: ₹3,979 Cr over the last 3 years, against ₹1,067 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹1,030 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is PI Industries' P/E ratio, and how does it compare with its own history? P I Industries Ltd's P/E is 30.7×, near the low end of its own history: it has been lower only 14% of the time. Its usual P/E (the middle reading) is 37.7×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹76.80. Why the multiple is where it is: over the past year earnings per share moved −20.4% while the price moved −38.9%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved −4.6% a year; about +6.7% a year came from earnings growth and about −11.3 percentage points from the multiple (the market paying less); over 10 years the price moved +10.1% a year; about +12.1% a year came from earnings growth and about −2.0 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the PI Industries business getting better or worse? P I Industries Ltd's business is getting worse. Revenue, profit and EPS growth are shrinking: revenue growth is −16.6% in the latest quarter, against +18.8% at its best in 12 quarters, with ROCE falling at 13.8%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does PI Industries earn on its capital? P I Industries Ltd earned a ROCE of 15% in FY26. Its return on capital used (ROIC) is 1.2 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 19.7% net margin and 0.50× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 19.7% net margin × 0.50× asset turnover × 1.19× leverage (assets divided by equity) ≈ 11.7% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 10.8% − 12.0% = −1.2 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The 10.8% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 13.7%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does PI Industries have too much debt? P I Industries Ltd has total debt of ₹342 Cr against shareholder equity of ₹11,231 Cr as of Jun 2026, so its debt is 0.03× its equity, which is very little. Year by year, that ratio went from 0.05 in FY22 to 0.03 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the PI Industries shareholding pattern? Domestic institutions raised their stake in P I Industries Ltd by 5.2 percentage points over 8 quarters, the biggest change among its owners. Domestic institutions now own 31.4% of the company. Foreign institutions moved −4.2 points over the same period, to 14.8%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Domestic institutions: +5.2 points over 8 quarters, to 31.4%; Foreign institutions: −4.2 points over 8 quarters, to 14.8%; Promoters: +0.0 points over 8 quarters, to 46.1%. Why the owners changed: foreign institutions moved −4.2 points and domestic institutions +5.2 points over 8 quarters, while promoters stayed about the same. One group of institutions took over shares from the other; it is not a change of mind by the people running the company. ## How far is PI Industries from balance-sheet trouble? For P I Industries Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does PI Industries rank in its industry? 38.3 out of 100, rank 23 of 25 in Pesticides/Agrochemicals, with 81% of the evidence available. P I Industries Ltd scores 38.3 out of 100 against the 25 companies it is compared with in Pesticides/Agrochemicals, ranking 23. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 5.8 + 15.4 + 9 + 8.1 = 38.3. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is PI Industries compared with? PI Industries ranks 23 of 25 Pesticides/Agrochemicals companies on the 4-Factor Sector Score, with 38.3 out of 100. 1. [Sharda Cropchem Ltd](https://www.sectoralpha.in/stocks/sharda-cropchem-ltd) SHARDACROP · basing · Most evidence points up · 100% evidence 71.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.5/35 · Revenue 17.3% · Profit 42.5% · Operating margin change 2 points · 100% evidence Capital efficiency 19.5/25 · ROCE 30.2% · Operating margin 16% · 100% evidence Valuation 19.2/20 · P/E 9.3× · PEG 0.3 · 100% evidence Relative strength 4.6/20 · Lead over its industry -14.3% · Lead over NIFTY 500 -22.1% · 1 year -23.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 28.5 + 19.5 + 19.2 + 4.6 = 71.8 · What this means: Earnings are strong; relative strength in its sector is -14.3% and the one-year return is -23.1%. 2. [Titan Biotech Ltd](https://www.sectoralpha.in/stocks/titan-biotech-ltd) turning · Most evidence points up · 83% evidence 70.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.1/35 · Revenue 31.8% · Profit 38.7% · Operating margin change 2 points · 83% evidence Capital efficiency 20.2/25 · ROCE 22.8% · Operating margin 21% · 95% evidence Valuation 5.4/20 · P/E 51.8× · PEG n/a · 50% evidence Relative strength 16.7/20 · Lead over its industry 38.3% · Lead over NIFTY 500 25.1% · 1 year 101.5% · 100% evidence · 4 of 12 weeks ahead Exact sum: 28.1 + 20.2 + 5.4 + 16.7 = 70.4 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. [Bayer CropScience Ltd](https://www.sectoralpha.in/stocks/bayer-cropscience-ltd) BAYERCROP · quiet · Evidence leans up · 81% evidence 63.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.3/35 · Revenue -2.8% · Profit 23.8% · Operating margin change 2 points · 88% evidence Capital efficiency 19.6/25 · ROCE 29.1% · Operating margin 20% · 100% evidence Valuation 13.4/20 · P/E 20× · PEG 1.28 · 100% evidence Relative strength 8.6/20 · Lead over its industry n/a · Lead over NIFTY 500 -20.8% · 1 year -33.3% · 25% evidence · 0 of 12 weeks ahead Exact sum: 22.3 + 19.6 + 13.4 + 8.6 = 63.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Punjab Chemicals & Crop Protection Ltd](https://www.sectoralpha.in/stocks/punjab-chemicals-crop-protection-ltd) PUNJABCHEM · quiet · Evidence leans up · 81% evidence 63.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.3/35 · Revenue 8.2% · Profit 43.5% · Operating margin change 1 points · 88% evidence Capital efficiency 13.6/25 · ROCE 18.6% · Operating margin 12% · 100% evidence Valuation 15.9/20 · P/E 17.4× · PEG 0.33 · 100% evidence Relative strength 9.8/20 · Lead over its industry n/a · Lead over NIFTY 500 -9.4% · 1 year -36.4% · 25% evidence · 6 of 12 weeks ahead Exact sum: 24.3 + 13.6 + 15.9 + 9.8 = 63.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Dharmaj Crop Guard Ltd](https://www.sectoralpha.in/stocks/dharmaj-crop-guard-ltd) DHARMAJ · losing its lead · Evidence leans up · 81% evidence 63.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.8/35 · Revenue 8.7% · Profit 13.2% · Operating margin change 1 points · 88% evidence Capital efficiency 14.7/25 · ROCE 16.8% · Operating margin 15% · 100% evidence Valuation 17.5/20 · P/E 14.3× · PEG 0.38 · 100% evidence Relative strength 12.2/20 · Lead over its industry n/a · Lead over NIFTY 500 4.7% · 1 year -9.9% · 25% evidence · 3 of 12 weeks ahead Exact sum: 18.8 + 14.7 + 17.5 + 12.2 = 63.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [India Pesticides Ltd](https://www.sectoralpha.in/stocks/india-pesticides-ltd) IPL · quiet · Evidence leans up · 81% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.6/35 · Revenue 17% · Profit 10.1% · Operating margin change -2 points · 88% evidence Capital efficiency 15.4/25 · ROCE 16.6% · Operating margin 14% · 100% evidence Valuation 18.2/20 · P/E 12× · PEG 0.36 · 100% evidence Relative strength 8.2/20 · Lead over its industry n/a · Lead over NIFTY 500 -23% · 1 year -40.7% · 25% evidence · 0 of 12 weeks ahead Exact sum: 17.6 + 15.4 + 18.2 + 8.2 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Advance Agrolife Ltd](https://www.sectoralpha.in/stocks/advance-agrolife-ltd) ADVANCE · breaking out · Evidence leans up · 64% evidence 58.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.1/35 · Revenue 48.4% · Profit 81.5% · Operating margin change 1 points · 88% evidence Capital efficiency 14.1/25 · ROCE 19.6% · Operating margin 11% · 100% evidence Valuation 10.3/20 · P/E 16.3× · PEG n/a · 15% evidence Relative strength 12.4/20 · Lead over its industry n/a · Lead over NIFTY 500 10.6% · 1 year -8.6% · 25% evidence · 12 of 12 weeks ahead Exact sum: 22.1 + 14.1 + 10.3 + 12.4 = 58.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Dhanuka Agritech Ltd](https://www.sectoralpha.in/stocks/dhanuka-agritech-ltd) DHANUKA · turning · Evidence leans up · 100% evidence 57.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 10.8/35 · Revenue 0% · Profit 0.7% · Operating margin change 0 points · 100% evidence Capital efficiency 19.6/25 · ROCE 25.9% · Operating margin 23% · 100% evidence Valuation 9.2/20 · P/E 14.4× · PEG 2.27 · 100% evidence Relative strength 17.4/20 · Lead over its industry 7.1% · Lead over NIFTY 500 -2.8% · 1 year -28.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 10.8 + 19.6 + 9.2 + 17.4 = 57 · What this means: Relative strength against the index is -2.8%, and revenue and profit growth are weak. 9. [Jubilant Ingrevia Ltd](https://www.sectoralpha.in/stocks/jubilant-ingrevia-ltd) JUBLINGREA · quiet · Evidence leans up · 93% evidence 54.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.0/35 · Revenue 15.4% · Profit 21.9% · Operating margin change 3 points · 100% evidence Capital efficiency 13.6/25 · ROCE 11.4% · Operating margin 15% · 100% evidence Valuation 6.7/20 · P/E 24.7× · PEG 2.26 · 65% evidence Relative strength 8.4/20 · Lead over its industry -2.6% · Lead over NIFTY 500 -11.7% · 1 year -19.1% · 100% evidence · 3 of 12 weeks ahead Exact sum: 26 + 13.6 + 6.7 + 8.4 = 54.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Meghmani Organics Ltd](https://www.sectoralpha.in/stocks/meghmani-organics-ltd) MOL · breaking out · Evidence leans up · 64% evidence 52.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.0/35 · Revenue -7.8% · Profit 100% · Operating margin change 7 points · 88% evidence Capital efficiency 9.5/25 · ROCE 6.7% · Operating margin 18% · 100% evidence Valuation 9.6/20 · P/E 20.8× · PEG n/a · 15% evidence Relative strength 11.0/20 · Lead over its industry n/a · Lead over NIFTY 500 -0.5% · 1 year -35% · 25% evidence · 11 of 12 weeks ahead Exact sum: 22 + 9.5 + 9.6 + 11 = 52.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [GSP Crop Science Ltd](https://www.sectoralpha.in/stocks/gsp-crop-science-ltd) GSPCROP · quiet · Too little evidence to rank firmly · 59% evidence 51.0 out of 100 Growth Capital Valuation Relative
12. [Epigral Ltd](https://www.sectoralpha.in/stocks/epigral-ltd) EPIGRAL · quiet · Evidence leans down · 81% evidence 49.6 out of 100 Growth Capital Valuation Relative
13. [Rallis India Ltd](https://www.sectoralpha.in/stocks/rallis-india-ltd) RALLIS · quiet · Evidence leans down · 85% evidence 48.4 out of 100 Growth Capital Valuation Relative
14. [Bharat Rasayan Ltd](https://www.sectoralpha.in/stocks/bharat-rasayan-ltd) BHARATRAS · quiet · Evidence leans down · 96% evidence 45.3 out of 100 Growth Capital Valuation Relative
15. [Bhagiradha Chemicals & Industries Ltd](https://www.sectoralpha.in/stocks/bhagiradha-chemicals-industries-ltd) BHAGCHEM · quiet · Evidence leans down · 96% evidence 44.7 out of 100 Growth Capital Valuation Relative
16. [Shivalik Rasayan Ltd](https://www.sectoralpha.in/stocks/shivalik-rasayan-ltd) SHIVALIK · Evidence leans down · 63% evidence 43.9 out of 100 Growth Capital Valuation Relative
17. [Excel Industries Ltd](https://www.sectoralpha.in/stocks/excel-industries-ltd) EXCELINDUS · quiet · Evidence leans down · 64% evidence 42.7 out of 100 Growth Capital Valuation Relative
18. [NACL Industries Ltd](https://www.sectoralpha.in/stocks/nacl-industries-ltd) NACLIND · basing · Evidence leans down · 96% evidence 42.0 out of 100 Growth Capital Valuation Relative
19. [Best Agrolife Ltd](https://www.sectoralpha.in/stocks/best-agrolife-ltd) BESTAGRO · quiet · Evidence leans down · 90% evidence 42.0 out of 100 Growth Capital Valuation Relative
20. [Sumitomo Chemical India Ltd](https://www.sectoralpha.in/stocks/sumitomo-chemical-india-ltd) SUMICHEM · quiet · Evidence leans down · 85% evidence 41.7 out of 100 Growth Capital Valuation Relative
21. [UPL Ltd](https://www.sectoralpha.in/stocks/upl-ltd) UPL · basing · Evidence leans down · 71% evidence 41.5 out of 100 Growth Capital Valuation Relative
22. [Insecticides India Ltd](https://www.sectoralpha.in/stocks/insecticides-india-ltd) INSECTICID · quiet · Evidence leans down · 96% evidence 40.5 out of 100 Growth Capital Valuation Relative
23. P I Industries Ltd this page PIIND · quiet · Evidence leans down · 81% evidence 38.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 5.8/35 · Revenue -16.6% · Profit -27.8% · Operating margin change -5 points · 88% evidence Capital efficiency 15.4/25 · ROCE 15% · Operating margin 22% · 100% evidence Valuation 9.0/20 · P/E 29.5× · PEG 1.71 · 100% evidence Relative strength 8.1/20 · Lead over its industry n/a · Lead over NIFTY 500 -23.1% · 1 year -41.3% · 25% evidence · 0 of 12 weeks ahead Exact sum: 5.8 + 15.4 + 9 + 8.1 = 38.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 24. [Astec Lifesciences Ltd](https://www.sectoralpha.in/stocks/astec-lifesciences-ltd) ASTEC · quiet · Most evidence points down · 71% evidence 32.7 out of 100 Growth Capital Valuation Relative
25. [Heranba Industries Ltd](https://www.sectoralpha.in/stocks/heranba-industries-ltd) HERANBA · quiet · Most evidence points down · 76% evidence 29.9 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Pesticides/Agrochemicals](https://www.sectoralpha.in/sectors/pesticides-agrochemicals), all 25 compared on one page. ## Which companies are close to PI Industries in size? PI Industries is the 2nd largest of 25 Pesticides/Agrochemicals companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: UPL. Just below it: Sumitomo Chemical India, Bayer CropScience, Jubilant Ingrevia, Sharda Cropchem and Dhanuka Agritech. ### Pesticides/Agrochemicals companies close in size

1. [UPL Ltd](https://www.sectoralpha.in/stocks/upl-ltd) ₹43,322 crore
2. P I Industries Ltd ₹31,861 crore
3. [Sumitomo Chemical India Ltd](https://www.sectoralpha.in/stocks/sumitomo-chemical-india-ltd) ₹15,728 crore
4. [Bayer CropScience Ltd](https://www.sectoralpha.in/stocks/bayer-cropscience-ltd) ₹14,636 crore
5. [Jubilant Ingrevia Ltd](https://www.sectoralpha.in/stocks/jubilant-ingrevia-ltd) ₹8,894 crore
6. [Sharda Cropchem Ltd](https://www.sectoralpha.in/stocks/sharda-cropchem-ltd) ₹6,000 crore
7. [Dhanuka Agritech Ltd](https://www.sectoralpha.in/stocks/dhanuka-agritech-ltd) ₹4,369 crore

[All 25 Pesticides/Agrochemicals companies, largest first](https://www.sectoralpha.in/sectors/pesticides-agrochemicals#all-companies)

### Companies close in size in other industries

1. [Mindspace Business Parks REIT](https://www.sectoralpha.in/stocks/mindspace-business-parks-reit) ₹31,980 crore · Real Estate Investment Trusts
2. [Endurance Technologies Ltd](https://www.sectoralpha.in/stocks/endurance-technologies-ltd) ₹31,978 crore · Auto Ancillaries - Diversified
3. P I Industries Ltd ₹31,861 crore
4. [Piramal Pharma Ltd](https://www.sectoralpha.in/stocks/piramal-pharma-ltd) ₹31,807 crore · Pharma - API & CRAMS
5. [Dhoot Transmission Ltd](https://www.sectoralpha.in/stocks/dhoot-transmission-ltd) ₹31,611 crore

## What else do people ask about PI Industries? ### What is PI Industries's share price today? P I Industries Ltd's share price is ₹2,185.00, −38.9% over the past year. The whole company is worth ₹33,151 Cr on the market. In the last 52 weeks it traded between ₹2,051 to ₹3,758; today it is 8% of the way up from the low, 19.7% below its 200-day average (as of 3 November 2026). ### What were PI Industries's latest quarterly results? P I Industries Ltd reported revenue of ₹1,702 Cr and net profit of ₹244 Cr for the Jun 2026 quarter. Revenue fell 10.4% and profit fell 39.0% compared with a year earlier. Earnings per share were ₹16.10. The operating margin was 22.0%, 5.0 percentage points lower than a year earlier (as of 3 November 2026). ### What is PI Industries's market cap? P I Industries Ltd's market capitalisation is ₹33,151 Cr at a share price of ₹2,185.00. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is PI Industries performing? P I Industries Ltd's share price has been falling for 57 weeks. In its latest quarter, revenue fell 10.4% and profit fell 39.0% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 30 weeks running (as of 3 November 2026). ### Will PI Industries's share price go up? This page does not forecast P I Industries Ltd's share price. What it shows instead: the share price is ₹2,185.00, and it has been falling for 57 weeks. Its P/E of 30.7× is higher than 14% of its own last 11 years (as of 3 November 2026). ### Does PI Industries have too much debt? No, P I Industries Ltd has little debt: its debt is 0.03× its equity, and its operating profit is 40 times its interest bill. FY26 borrowings were ₹342 Cr against equity of ₹11,230 Cr. So the returns on this page come from the business, not borrowed money (as of 3 November 2026). ### Where is PI Industries in its business cycle? P I Industries Ltd's FY26 operating margin was 26.0%, against a 13-year range of 19.0% to 28.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 22.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the PI Industries story? The main question: the P/E is near the low end of its own history, higher than only 14% of past readings, but results are getting worse. A low multiple can stay low until the quarters turn. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is PI Industries a stock worth studying right now? What the numbers show: P I Industries Ltd's P/E is near the low end of its own history, higher than only 14% of past readings, and its quarterly results are still getting worse. The main open question: whether results start to improve. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a PI Industries share price forecast for 2026? What management itself guided: FY27 revenue growth in the low double digits, with the positive trajectory maintained. ## Lists

- 52 week high & low: https://www.sectoralpha.in/52-week-high-stocks-india
- Small & mid cap stocks: https://www.sectoralpha.in/small-cap-stocks-india

This is research, not advice. We’re not SEBI-registered.